Intrinsic Value of S&P & Nasdaq Contact Us

Elite Pharmaceuticals, Inc. ELTP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
65/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ELTP

Elite Pharmaceuticals, Inc. (ELTP) has a market capitalization of $409.26M and trades at $0.38. The 52-week range is 0.27-0.82.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -95, Earnings Per Share (EPS) of $0.00, annual revenue of $84.04M.

The stock has a beta of 0.44, operates in the Healthcare sector.

Trading Data
Current Price$0.38
52-Week Range0.27-0.82
Volume70.28K
Avg Volume (30D)711.79K
Market Cap$409.26M
Beta (1Y)0.44
Company
IPO Date2000-02-24
Employees64
CEONasrat Hakim
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS28659T2006
CUSIP28659T200
Income (Latest Year)
Revenue$84.04M
Gross Profit$40.09M
EBITDA$2.84M
Operating Income$19.6M
Net Income$-4.31M
EPS$0.00
EPS Diluted$0.00
Shares Outstanding$1.07B
Balance Sheet (Latest Year)
Total Assets$96.39M
Current Assets$57.74M
Cash & ST Investments$11.32M
Total Liabilities$42.87M
Total Debt$10.91M
Net Debt$-400.5K
Total Equity$53.52M
Debt / Equity0.20
Valuation Ratios
P/E Ratio-95
P/S Ratio4.87
P/B Ratio7.65
EV/EBITDA (approx)144
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message